Novanta Inc (NOVTU) Stock Price & Analysis
Novanta Inc (NOVTU) fell 0.78% to USD 60.78 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
NOVTU last closed at USD 61.26; the session ranged USD 60.45–61.35 on volume of 6,329 shares. Market capitalization is —, with a 52-week range of USD 47.57–75.07 (NMS). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 60.78 |
|---|---|
| Change | ▼ 0.78% (down) |
| Previous Close | USD 61.26 |
| Open | USD 60.76 |
| Day Range | USD 60.45 – 61.35 |
| 52-Week Range | USD 47.57 – 75.07 |
| Volume | 6,329 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (NOVTU)
Nexqual's technical model rates NOVTU "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 39.67 (neutral) |
| vs SMA50 | Below (USD 65.8) |
| MACD | -1.16 (negative) |
Analyst Ratings (NOVTU)
Wall Street analysts rate NOVTU "None", per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | None |
|---|
Earnings (NOVTU)
| Revenue Estimate | $262.30M |
|---|
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (NOVTU)
| Total Revenue | $1.00B |
|---|---|
| Revenue Growth (YoY) | +10.40% |
| Gross Margin | +44.23% |
| Operating Margin | +11.70% |
| Profit Margin | +5.35% |
| ROE | +5.16% |
| Debt / Equity | 22.22 |
| Current Ratio | 3.56 |
| Total Cash | $388.80M |
| Total Debt | $291.34M |
| Free Cash Flow | $87.25M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (NOVTU)
Nexqual rates Novanta Inc's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Mixed — Revenue +3.3% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 44%, operating 12% |
| Balance Sheet | Strong — $389M cash vs $291M debt, net cash position |
| Cash Flow | Solid — FCF $87M, 9% margin |
| Efficiency | Mixed — ROE 5%, ROA 4.6% |
Ownership (NOVTU)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +92.37% |
| Float | 35.35M |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (NOVTU)
Novanta Inc is led by Matthijs Glastra (age 56), CEO & Chairman of the Board, per Nexqual as of July 25, 2026 at 02:21 UTC.
| CEO & Chairman of the Board | Matthijs Glastra (age 56) |
|---|---|
| Chief Financial Officer | Robert J. Buckley (age 51) |
| Co-Chief Operating Officer of Automation Enabling Technologies | Charles G. Ravetto (age 54) |
| Co-Chief Operating Officer of Medical Solutions | John Lesica (age 49) |
| Senior Vice President of Corporate Development | Nissia Sabri |
Major Backers & Investors (NOVTU)
Notable institutional backers of Novanta Inc include T. Rowe Price, Aequim Alternative Investments LP, Two Sigma Investments, LP, according to Nexqual as of July 25, 2026 at 02:21 UTC.
Active Investors
| Investor | Stake |
|---|---|
| T. Rowe Price | 18.33% |
| Aequim Alternative Investments LP | 9.09% |
| Two Sigma Investments, LP | 7.98% |
| Walleye Capital LLC | 7.05% |
| Citadel | 6.09% |
| TPG GP A, LLC | 6.02% |
| Magnetar Financial LLC | 4.55% |
| Wells Fargo & Company | 4.45% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 15.69% |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
From Novanta Inc's Latest SEC 10-K Filing (filed 2026-02-23)
Key Strengths & Strategy (as disclosed to the SEC)
- Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally.
- The company operates Automation Enabling Technologies and Medical Solutions segments.
- The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles.
- This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MCHPP | Microchip Technology Incorporat | USD 67.35 | ▼ 6.51% |
| FOUR-PA | Shift4 Payments, Inc. 6.00% Ser | USD 60.76 | ▲ 0.63% |
| HPE-PC | Hewlett Packard Enterprise Comp | USD 123.46 | ▼ 1.2% |
| CORZZ | Core Scientific, Inc. - Tranche | USD 22.67 | ▼ 5.74% |
| PICS | PicS N.V. | USD 11.85 | ▼ 4.13% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.